6. Parkinson disease Clinical trials / Disease details


Clinical trials : 2,307 Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05220072
(ClinicalTrials.gov)
August 28, 202118/11/2021Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of Carbon-14 BIA 28-6156 in Healthy Male SubjectsParkinson DiseaseDrug: Carbon-14 BIA 28-6156Bial R&D Investments, S.A.NULLCompleted30 Years65 YearsMale6Phase 1United Kingdom